Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease

Gastroenterology

Volumn 141, Issue 5, 2011, Pages 1612-1620

  Singh, Harminder ^a   Nugent, Zoann ^a,b   Demers, Alain A ^a,b,c   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Crohn's Disease; Inflammatory Bowel Disease; Nonmelanoma Skin Cancer; Pharmacoepidemiology; Side Effects; Therapy; Thiopurines; Ulcerative Colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE;

ADULT; AMBULATORY CARE; ARTICLE; BASAL CELL SKIN CANCER; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NONMELANOMA SKIN CANCER; PRIORITY JOURNAL; SKIN CANCER; SOCIAL STATUS; SQUAMOUS CELL SKIN CANCER;

EID: 80054865266     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.07.039     Document Type: Article

References (52)

1. Canadian Cancer Society/National Cancer Institute of Canada. Canadian cancer statistics 2009. Toronto, Canada, 2009.
2. Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006;55:490-500. (Pubitemid 44209289)
3. Jensen AO, Bautz A, Olesen AB, et al. Mortality in Danish patients with nonmelanoma skin cancer, 1978-2001. Br J Dermatol 2008;159:419-425. (Pubitemid 352009875)
4. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010;375:673-685.
5. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17.
6. Comeau S, Jensen L, Cockfield SM, et al. Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience. Transplantation 2008;86:535-541.
7. Veness MJ, Harris D. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Australas Radiol 2007;51:12-20. (Pubitemid 46087986)
8. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177-186. (Pubitemid 29072794)
9. Herman S, Rogers HD, Ratner D. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients. Skinmed 2007;6:234-238.
10. Ulrich C, Kanitakis J, Stockfleth E, et al. Skin cancer in organ transplant recipients - where do we stand today? Am J Transplant 2008;8:2192-2198.
11. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:188-193.
12. Beaugerie L, Sokol H, Seksik P. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye. Dig Dis 2009;27:375-381.
13. Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis 2009;15:1399-1409.
14. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237-241. (Pubitemid 40139240)
15. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001;36:2-15. (Pubitemid 32147176)
16. Duricova D, Pedersen N, Elkjaer M, et al. Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 2010;16:347-353.
17. Jess T, Gamborg M, Munkholm P, et al. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007;102:609-617.
18. von Roon AC, Reese G, Teare J, et al. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007;50:839-855.
19. Armstrong RG, West J, Card TR. Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol 2010;105:1604-1609.
20. Singh H, Demers AA, Nugent Z, et al. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology 2009;136:451-458.
21. Kozyrskyj AL, Mustard CA. Validation of an electronic, population-based prescription database. Ann Pharmacother 1998;32:1152-1157. (Pubitemid 28543459)
22. Roos LL, Mustard CA, Nicol JP, et al. Registries and administrative data: organization and accuracy. Med Care 1993;31:201-212.
23. Robinson JR, Young TK, Roos LL, et al. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care 1997;35:932-947. (Pubitemid 127453475)
24. Hotes Ellison J, Wu XC, McLaughlin C, et al., eds. Cancer in North America: 1999-2003. Volume one: incidence. Sacramento, CA: North American Association of Central Cancer Registries Inc, 2006:II-325.
25. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916-924. (Pubitemid 29230706)
26. Bernstein CN, Nugent Z, Longobardi T, et al. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol 2009;104:2774-2778.
27. Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008;6:41-45. (Pubitemid 50008413)
28. Longobardi T, Bernstein CN. Utilization of health-care resources by patients with IBD in Manitoba: a profile of time since diagnosis. Am J Gastroenterol 2007;102:1683-1691. (Pubitemid 47206679)
29. Green C, Elliott L, Beaudoin C, et al. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006;164:615-623. (Pubitemid 44453488)
30. Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005;23:3733-3741.
31. Martens PJ, Frohlich N, Carriere KC, et al. Embedding child health within a framework of regional health: population health status and sociodemographic indicators. Can J Public Health 2002;93(Suppl 2):S15-S20. (Pubitemid 36157488)
32. Martens PJ, Derksen S, Gupta S. Predictors of hospital readmission of Manitoba newborns within six weeks postbirth discharge: a population-based study. Pediatrics 2004;114:708-713. (Pubitemid 41529528)
33. Frohlich N, Mustard C. A regional comparison of socioeconomic and health indices in a Canadian province. Soc Sci Med 1996;42:1273-1281.
34. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006;154:498-504. (Pubitemid 43382659)
35. Pedersen N, Duricova D, Elkjaer M, et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol 2010;105:1480-1487.
36. Long MD, Herfarth HH, Pipkin C, et al. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2010;8:268-274.
37. van Schaik FD, van Oijen MG, Smeets HM, et al. The risk of non-melanoma skin cancer in patients with inflammatory bowel disease using thiopurines is not increased. Clin Gastroenterol Hepatol 2011;9:449-450.e1.
38. Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009;27:2356-2362.
39. Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 2000;11:891-897. (Pubitemid 32005300)
40. Mellemkjaer L, Olsen JH, Frisch M, et al. Cancer in patients with ulcerative colitis. Int J Cancer 1995;60:330-333.
41. Ekbom A, Helmick C, Zack M, et al. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991;67:2015-2019.
42. van HS, Aarts MJ, Louwman WJ, et al. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands. Br J Dermatol 2009;161:840-845.
43. Jess T, Winther KV, Munkholm P, et al. Intestinal and extraintestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004;19:287-293. (Pubitemid 38253503)
44. Winther KV, Jess T, Langholz E, et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004;2:1088-1095. (Pubitemid 40037640)
45. Demers AA, Nugent Z, Mihalcioiu C, et al. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 2005;53:320-328. (Pubitemid 40979591)
46. Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-519.
47. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005;309:1871-1874. (Pubitemid 41325100)
48. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854-862. (Pubitemid 32173312)
49. Metge CJ, Blanchard JF, Peterson S, et al. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001;96:3348-3355. (Pubitemid 34016659)
50. Lucke TW, Hole DJ, Mackie RM. An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol 1997;137:761-763. (Pubitemid 27496194)
51. Blanchard JF, Bernstein CN, Wajda A, et al. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-335. (Pubitemid 32756629)
52. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006;101:1559-1568. (Pubitemid 43980630)